Interferon-lambda: New role in intestinal symptoms of COVID-19

The tremendous public health and economic impact of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a huge challenge globally. There is increasing evidence that SARS-CoV-2 induces intestinal infections. Type III interferon (IFN-...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yi-Yang, Wang, Liu-Can, Yang, Feng, Yu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122791/
https://www.ncbi.nlm.nih.gov/pubmed/37155525
http://dx.doi.org/10.3748/wjg.v29.i13.1942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122791/
https://www.ncbi.nlm.nih.gov/pubmed/37155525
http://dx.doi.org/10.3748/wjg.v29.i13.1942

Ejemplares similares